U.S. Paper and Forestry Products Stock News

NasdaqGS:CARL
NasdaqGS:CARLMedical Equipment

Carlsmed (CARL) Revenue Growth At 85.9% Tests Bearish Profitability Narratives

Carlsmed (CARL) has reported its FY 2025 fourth quarter with total revenue of US$15.2 million and a basic EPS loss of US$0.32, while on a trailing twelve month basis revenue was US$50.5 million and basic EPS was a loss of US$2.12. The company has seen quarterly revenue move from US$9.4 million in Q4 2024 to US$15.2 million in Q4 2025, as basic EPS shifted from a loss of US$1.14 to a loss of US$0.32 over the same period, setting up a story where faster top line expansion is still being weighed...
NasdaqGS:SPOK
NasdaqGS:SPOKWireless Telecom

Spok Holdings (SPOK) Dividend Coverage Concerns Reinforce Bearish Narratives Despite 10.49% Yield

Spok Holdings (SPOK) has wrapped up FY 2025 with fourth quarter revenue of US$33.9 million and basic EPS of US$0.14, while trailing 12 month revenue sits at US$139.7 million and EPS at US$0.77. Over the past six quarters, the company has seen quarterly revenue move in a tight band between US$33.9 million and US$36.3 million. Basic EPS has ranged from US$0.14 to US$0.25, and trailing 12 month EPS has edged from US$0.73 to US$0.81 before landing at US$0.77 most recently. With net profit margins...
NYSE:NLY
NYSE:NLYMortgage REITs

A Look At Annaly Capital Management’s Valuation As Income Returns Draw Fresh Attention

Why Annaly Capital Management (NLY) Is Back on Income Investors’ Radar Annaly Capital Management (NLY) has drawn fresh attention after a period where returns have moved in different directions over various timeframes, putting its income focused mortgage REIT model back in focus for investors. The stock shows a 1 day return of 1.17%, with the past week slightly positive and the past month showing a 4.43% decline. Over the past 3 months and year to date, returns are positive, and the 1 year and...
NasdaqGS:GDRX
NasdaqGS:GDRXHealthcare Services

GoodRx Holdings GDRX Margin Improvement Reinforces Bullish Profitability Narratives

GoodRx Holdings (GDRX) FY 2025 Earnings Snapshot GoodRx Holdings (GDRX) closed out FY 2025 with Q4 revenue of US$194.8 million and basic EPS of US$0.02. Trailing twelve month figures came in at US$796.9 million of revenue and EPS of US$0.09 on net income of US$30.4 million. The company has seen quarterly revenue move from US$198.6 million in Q4 2024 to a range of US$195.3 million to US$203.1 million through 2025, with EPS running between US$0.00 and US$0.04 across those same periods. With...
NYSE:AI
NYSE:AISoftware

C3.ai (AI) Q3 Loss Worsening To US$0.94 EPS Reinforces Bearish Profitability Concerns

C3.ai (AI) just posted its Q3 2026 numbers, with revenue of US$53.3 million and a basic EPS loss of US$0.94, while trailing twelve month revenue came in at US$307.4 million and EPS at a loss of US$3.17. Over the last six reported quarters, the company has seen quarterly revenue move from US$94.3 million in Q2 2025 to US$53.3 million in Q3 2026, with basic EPS losses ranging between US$0.52 and US$0.94. This sets up an earnings story that is centered on loss-making margins and the pace at...
NasdaqGM:PRCT
NasdaqGM:PRCTMedical Equipment

PROCEPT BioRobotics (PRCT) Quarterly Loss Deepens Challenging Bullish Margin Expansion Narrative

PROCEPT BioRobotics (PRCT) just closed out FY 2025 with Q4 revenue of US$76.4 million and a basic EPS loss of US$0.53. The company also reported a trailing 12 month revenue base of US$308.1 million and an EPS loss of US$1.72. Over recent periods, quarterly revenue has moved from US$58.4 million in Q3 2024 to US$68.2 million in Q4 2024, then to US$69.2 million in Q1 2025, US$79.2 million in Q2 2025, US$83.3 million in Q3 2025, and US$76.4 million in Q4 2025. Over the same stretch, quarterly...
NYSE:MIAX
NYSE:MIAXCapital Markets

Miami International Holdings Q4 Profit Rebound Tests Bullish Earnings Recovery Narrative

Miami International Holdings FY 2025 earnings snapshot Miami International Holdings (MIAX) has reported a mixed FY 2025 finish, with fourth quarter revenue of US$369.4 million and EPS of US$0.34. The trailing twelve months still reflect a loss of US$70.0 million on revenue of US$1.4 billion and a TTM EPS loss of US$0.82. In recent quarters the company’s quarterly revenue moved from US$323.9 million in Q4 2024 to US$369.4 million in Q4 2025, while EPS shifted from US$0.05 in Q4 2024 to US$0.34...
NYSE:DHR
NYSE:DHRLife Sciences

Assessing Danaher (DHR) Valuation After Recent Share Price Weakness

Why Danaher stock may be on your radar today Danaher (DHR) has been drawing attention after recent share price moves, with the stock around $209.36 and showing mixed returns over the past year, month, and past 3 months. See our latest analysis for Danaher. Recent trading has been softer, with a 30 day share price return of an 11.19% decline and a 1 year total shareholder return of 2.41%, so near term momentum looks weaker than the longer term picture. If Danaher’s recent moves have you...
NasdaqGS:SFNC
NasdaqGS:SFNCBanks

Simmons First National (SFNC) Net Interest Margin Rebound Tests Bearish Profitability Narratives

Simmons First National (SFNC) closed out FY 2025 with fourth quarter revenue of US$233.9 million and basic EPS of US$0.54, following a turbulent year in which trailing twelve month figures show revenue of US$37.4 million and a basic EPS loss of US$2.96. Over recent quarters, the company has seen quarterly revenue move from US$162.7 million in Q3 2024 to US$195.2 million in Q4 2024, then to US$182.8 million, US$202.2 million and US$233.9 million through Q1 to Q4 2025. Basic EPS shifted from...
NasdaqGS:CHYM
NasdaqGS:CHYMDiversified Financial

Chime Financial (CHYM) Q2 Loss Of US$923m Fuels Bearish Profitability Narratives

Chime Financial (CHYM) closed out FY 2025 with Q4 revenue of US$596.4 million and a basic EPS loss of US$0.12. Trailing 12 month figures show revenue of about US$2.2 billion and a basic EPS loss of US$4.27, keeping the story firmly in loss-making territory. Over recent periods the company has seen revenue move from US$475.2 million in Q4 2024 to US$596.4 million in Q4 2025. This has come alongside quarterly EPS that has swung between a profit of US$0.20 in Q1 2025 and a loss of US$7.29 in Q2...
NYSE:BV
NYSE:BVCommercial Services

Assessing BrightView Holdings (BV) Valuation After Expanded Golf Management Role At The Villages

BrightView Holdings (BV) shares are in focus after its BrightView Landscapes unit expanded its golf management role at The Villages in Florida, where it now oversees more than half of the community’s 400 golf holes. See our latest analysis for BrightView Holdings. The latest contract win comes as BrightView’s 30 day share price return of 5.39% and 90 day share price return of 10.06% point to building momentum. At the same time, the 3 year total shareholder return of about 12x contrasts with a...
NYSE:UHS
NYSE:UHSHealthcare

Universal Health Services Q4 EPS Strength Reinforces Bullish Margin Narrative

Universal Health Services (UHS) has wrapped up FY 2025 with fourth quarter revenue of US$4.5b and basic EPS of US$7.19, backed by net income of US$445.9m. The company has seen quarterly revenue move from US$4.1b in Q4 2024 to US$4.5b in Q4 2025, while basic EPS stepped up from US$5.07 to US$7.19 over the same period. On a trailing twelve month view, net profit margin sits at 8.6% versus 7.2% a year earlier, giving investors a clearer view of how earnings are converting into profit. See our...
NYSE:CWT
NYSE:CWTWater Utilities

California Water Service Group (CWT) Margin Compression Tests Bullish Earnings Narrative

California Water Service Group (CWT) has just wrapped up FY 2025 with fourth quarter revenue of US$220 million and basic EPS of US$0.19, alongside net income of US$11.5 million. The company has seen quarterly revenue move from US$222 million and EPS of US$0.33 in Q4 2024 to US$220 million and EPS of US$0.19 in Q4 2025. On a trailing 12 month basis, EPS was US$2.15 on revenue of about US$1.0 billion and net income of US$128.2 million, setting up a story where investors are weighing earnings...
NYSE:QSR
NYSE:QSRHospitality

Restaurant Brands Investor Day Clarifies Growth Targets And Simplification Plan

Restaurant Brands International held its 2026 Investor Day, offering a midpoint update on its long-term plan. The company reaffirmed its multiyear growth targets and detailed progress on its existing initiatives. Management outlined a roadmap to simplify its structure, including plans to sunset the Restaurant Holdings segment by 2027. The event also highlighted priorities for capital allocation and operational focus over the medium term. Restaurant Brands International, traded as NYSE:QSR,...
NasdaqCM:MDXG
NasdaqCM:MDXGBiotechs

MiMedx Group (MDXG) Revenue Jump To US$118.1 Million Tests Slow Growth Narrative

MiMedx Group (MDXG) has wrapped up FY 2025 with fourth quarter revenue of about US$118.1 million and basic EPS of roughly US$0.10, while trailing twelve month figures sit at around US$418.6 million of revenue and US$0.33 of basic EPS. Over the past few quarters, the company has seen revenue move from US$84.1 million in Q3 2024 to US$92.9 million in Q4 2024 and then to US$118.1 million in Q4 2025, with quarterly basic EPS ranging from about US$0.05 to US$0.11 across that stretch. With a...
NasdaqGS:GERN
NasdaqGS:GERNBiotechs

Geron (GERN) Q4 Loss Of US$31.1 Million Tests Bullish Profitability Narrative

Geron (GERN) has just posted its FY 2025 results, with Q4 total revenue of US$48.0 million and a basic EPS loss of US$0.05, alongside trailing twelve month revenue of US$183.9 million and a TTM basic EPS loss of US$0.13. Over recent periods the company has seen quarterly revenue move between US$39.6 million and US$49.0 million, while basic EPS losses have ranged from US$0.02 to US$0.05 per quarter. This sets the backdrop for how investors assess the current TTM net loss of US$85.8 million and...
NYSE:A
NYSE:ALife Sciences

Agilent Technologies (A) Margin Slippage Challenges Bullish Earnings Improvement Narrative

Agilent Technologies (A) has opened fiscal Q1 2026 with revenue of US$1.8b and basic EPS of US$1.08, setting the tone against a trailing twelve month picture that shows US$7.1b in revenue and EPS of US$4.55. Over the past year, the company has seen quarterly revenue move from US$1.70b in Q4 2024 to US$1.86b in Q4 2025 and then to US$1.80b in Q1 2026. Basic EPS shifted from US$1.23 to US$1.53 and now US$1.08, leaving investors focused on how the 18.3% trailing net margin shapes the quality of...
NasdaqGS:STGW
NasdaqGS:STGWMedia

Is Stagwell (STGW) Pricing Reflect Its DCF Upside And High P/E Multiple After NewVoices.ai?

If you are wondering whether Stagwell is attractively priced or just cheap for a reason, you are in the right place to get a clearer view of what the current share price might actually represent. The stock closed at US$4.85 recently, with a 2.3% gain over the last 7 days, a 21.5% decline over the past month, and returns of 2.5% year to date, but a 23.7% decline over the past year and a 36.0% decline over three years. Recent coverage of Stagwell has focused on broader media and marketing...
NYSE:GMED
NYSE:GMEDMedical Equipment

Globus Medical (GMED) Net Margin Reset Tests Bullish Long Term Earnings Narratives

Globus Medical (GMED) just closed out FY 2025 with Q4 revenue of US$826.4 million and basic EPS of US$1.05. Trailing twelve month revenue reached about US$2.9 billion and EPS came in at US$3.98, setting the stage for a sharply different earnings profile compared with a year earlier. Over the past six quarters, the company has seen quarterly revenue move from US$625.7 million in Q3 2024 to US$826.4 million in Q4 2025, with basic EPS shifting from US$0.38 to US$1.05 across the same period. This...
NYSE:EE
NYSE:EEOil and Gas

Excelerate Energy Q4 Margin Compression Tests Bullish Growth Narrative

Excelerate Energy (EE) has wrapped up FY 2025 with fourth quarter revenue of US$317.6 million, basic EPS of US$0.29 and net income of US$9.1 million. Trailing twelve month revenue sits at about US$1.2 billion, with basic EPS of US$1.31 and net income of US$39.2 million. The company has seen quarterly revenue move from US$274.6 million in Q4 2024 to US$317.6 million in Q4 2025. EPS has run between US$0.15 and US$0.48 over the last four reported quarters. These headline numbers can be weighed...
NYSE:WTRG
NYSE:WTRGWater Utilities

Essential Utilities (WTRG) Margin Compression Challenges Long‑Running Earnings Growth Narrative

Essential Utilities (WTRG) has wrapped up FY 2025 with fourth quarter revenue of US$699.1 million and basic EPS of US$0.47, alongside trailing 12 month revenue of US$2.5 billion and EPS of US$2.20, setting a clear earnings picture for investors to work with. The company has seen revenue move from US$2.1 billion and EPS of US$2.17 on a trailing basis in Q4 2024 to US$2.5 billion and EPS of US$2.20 in Q4 2025, while quarterly revenue has shifted from US$604.4 million a year ago to US$699.1...
NasdaqGS:SRPT
NasdaqGS:SRPTBiotechs

Sarepta Therapeutics (SRPT) Q4 Loss Deepens And Tests Bullish Profitability Narrative

Sarepta Therapeutics (SRPT) closed out FY 2025 with Q4 revenue of US$442.9 million and a basic EPS loss of US$3.93, alongside a full year trailing net loss of US$713.4 million on US$2.2 billion of revenue. Over the last six quarters in the data, revenue has ranged from US$399.4 million to US$744.9 million per quarter. Basic EPS has swung between a profit of US$2.01 and a loss of US$4.60, highlighting sharp shifts in margins that keep profitability firmly in focus for investors. See our full...
NYSE:HNI
NYSE:HNICommercial Services

Evaluating HNI (HNI) After Recent Share Pullback And Perceived Valuation Gap

HNI stock performance snapshot and business context HNI (HNI) has recently seen mixed share performance, with a 1 day decline of 1.17% and a 9.15% drop over the past week, while returns over the past 3 months remain positive. For context, the company reports annual revenue of US$2.84b and net income of US$54.2m, with recent annual revenue and net income growth figures of 32.84% and 55.29%, respectively. See our latest analysis for HNI. HNI’s recent share price softness, including a 9.15% 7...